openPR Logo
Press release

Pancreatic Cancer Diagnostic Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033

Pancreatic Cancer Diagnostic Global Market Report 2024: Key

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Pancreatic Cancer Diagnostic Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The pancreatic cancer diagnostic market size has grown strongly in recent years. It will grow from $3.92 billion in 2023 to $4.21 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to growing genomic and molecular profiling, chemotherapy developments, radiation therapy refinements, research on pancreatic cancer genetics, awareness campaigns and early detection efforts.

The pancreatic cancer diagnostic market size is expected to see strong growth in the next few years. It will grow to $5.74 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to liquid biopsy advancements, targeted therapies, artificial intelligence in diagnostics, personalized medicine approaches, early detection biomarkers, neoadjuvant therapies. Major trends in the forecast period include immunotherapy research, advancements in imaging technologies, surgical innovations, global collaborative research initiatives, integration of big data analytics.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=11981&type=smp

Market Segmentation:
The pancreatic cancer diagnostic market covered in this report is segmented -
1) By Product: Instruments, Consumables, Services
2) By Treatment: Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy
3) By Cancer Type: Exocrine, Adenocarcinoma, Squamous Cell Carcinoma, Adenosquamous Carcinoma, Colloid Carcinoma, Endocrine
4) By Test Type: Imaging Test, Biopsy, Blood Test, Genomic Test, Other Test Types
5) By End-User: Hospitals, Diagnostic Centers, Cancer Research Centers, Academic Institutes, Ambulatory Surgical Centers, Other End-Users

Major Driver - Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence Of Pancreatic Cancer
The rise in the prevalence of pancreatic cancer is expected to propel the growth of the pancreatic cancer diagnostic market going forward. Pancreatic cancer refers to a condition in which the tissues of the pancreas develop malignant (cancer) cells. The rise in pancreatic cancer is mostly driven by smoking, diabetes, chronic pancreatitis, a family history of pancreatic cancer, inflammation of the pancreas, and some genetic disorders. Diagnosis in pancreatic cancer is crucial for guiding treatment decisions, determining the stage of cancer, identifying the specific characteristics of the tumor, and tailoring treatment approaches to improve outcomes and optimize patient care. For instance, in 2023, according to the American Society of Clinical Oncology, a US-based professional organization, in the United States, 64,050 individuals (33,130 men and 30,920 women) are anticipated to be diagnosed with pancreatic cancer in 2023. It is the eighth most frequent cancer in women and the tenth most frequent in men. The frequency of new instances of pancreatic cancer has increased by about 1% per year in both men and women. Therefore, the rise in the prevalence of pancreatic cancer is driving the growth of the pancreatic cancer diagnostic market.

Competitive Landscape:
Major companies operating in the pancreatic cancer diagnostic market report are Pfizer Inc., Hitachi Medical Corporation, F. Hoffmann-La Roche AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories Inc., Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, Becton Dickinson and Company, Koninklijke Philips N.V., GE Healthcare Bio Sciences AB, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Biological Dynamics Inc., Berg LLC, Abcodia Ltd., Acobiom, Amplified Sciences LLC, Avant Diagnostics Inc., Axim Biotechnologies Inc., Alaunus Biosciences Inc., Advanced Marker Discovery SL, Anixa Diagnostics Corporation

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-diagnostic-global-market-report

Top Trend - Prestige Biopharma Launches Groundbreaking Pauf-Detecting Diagnostic Kit For Early Detection Of Pancreatic Cancer
Product innovations are a key trend gaining popularity in the pancreatic cancer diagnostic market. Companies operating in the pancreatic cancer diagnostic market are adopting innovative solutions to sustain their position in the market. For instance, in March 2023, Prestige Biopharma Limited, a Singapore-based biopharmaceutical company, launched the first-in-class PAUF-detecting diagnostic kit, a powerful instrument for the early detection of pancreatic cancer. PAUF (Pancreatic Adenocarcinoma Upregulated Factor) is a unique tumor-specific biomarker associated with early metastasis and overexpression in about 80% of pancreatic cancer cases. The innovative diagnostic technique has high sensitivity and specificity for identifying PAUF. Preliminary studies showed that the expression level of PAUF in the blood plasma of pancreatic cancer patients is almost 1.9 times higher than that of healthy individuals, according to Prestige Biopharma's IDC (Innovative Discovery Center).

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Pancreatic Cancer Diagnostic Market Characteristics
3. Pancreatic Cancer Diagnostic Market Trends And Strategies
4. Pancreatic Cancer Diagnostic Market - Macro Economic Scenario
5. Pancreatic Cancer Diagnostic Market Size And Growth
…..
27. Pancreatic Cancer Diagnostic Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pancreatic Cancer Diagnostic Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033 here

News-ID: 3429801 • Views:

More Releases from The Business research company

Market Segmentation, Dynamics, and Competitive Landscape in the Antenna, Transducer, and Radome Industry
Market Segmentation, Dynamics, and Competitive Landscape in the Antenna, Transdu …
The antenna, transducer, and radome industry is set for notable expansion over the coming years, driven by technological advancements and growing demand across multiple sectors. Industry stakeholders are preparing to capitalize on emerging trends and increasing investments that are shaping the future of communication and defense systems. Let's explore the market size, key players, evolving trends, and segment breakdowns to understand this dynamic field better. Market Size Expectations and Growth Trajectory
Emerging Sub-Segments Transforming the Converting Equipment Market Landscape
Emerging Sub-Segments Transforming the Converting Equipment Market Landscape
The converting equipment market is poised for significant expansion as industries increasingly prioritize efficiency and sustainability. With advancements in manufacturing technologies and rising demand across various sectors, this market is set to experience dynamic growth and evolving trends that promise to reshape packaging and converting processes. Converting Equipment Market Size and Projected Growth Through 2030 The converting equipment market is forecasted to expand substantially, reaching a total value of $56.38 billion
Analysis of Key Market Segments Driving the Airport Moving Walkways Market
Analysis of Key Market Segments Driving the Airport Moving Walkways Market
The airport moving walkways market is poised for significant expansion as airports worldwide strive to enhance passenger movement and efficiency. Rapid advancements in technology and growing investments in smart airport infrastructure are setting the stage for robust growth in this sector. Let's explore the current market size projections, major players, emerging trends, and segmentation insights shaping the airport moving walkways industry. Forecasted Market Value and Growth Trajectory of the Airport Moving
Competitive Landscape: Key Market Leaders and Rising Competitors in the Construction Machinery Industry
Competitive Landscape: Key Market Leaders and Rising Competitors in the Construc …
The construction machinery sector is on the verge of remarkable expansion as global infrastructure needs intensify and technological advancements reshape the industry. With growing investments in smarter, more efficient equipment and an increasing shift toward electrification, this market is set to experience substantial growth in the years ahead. Let's explore the current market value, key players, emerging trends, and the major segments propelling this industry forward. Construction Machinery Market Size and

All 5 Releases


More Releases for Pancreatic

Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Pancreatic Cancer Diagnostic Industry Market Size Be by 2025? The sector dedicated to diagnosing pancreatic cancer has experienced significant upward momentum lately, projecting an expansion from a valuation of $4.24 billion in 2024 to $4.54 billion in 2025, reflecting a steady compound annual growth rate of
Growing Pancreatic Cancer Cases : Pivotal Factor Influencing Pancreatic Cancer D …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Pancreatic Cancer Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for pancreatic cancer drugs has seen consistent growth over the past few years. An escalation from $3.96 billion in 2024 to $4.1 billion in 2025 is projected, marking a compound annual
Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Pancreatic Cancer Diagnostic Market Through 2025? The market size for pancreatic cancer diagnostics has been witnessing robust growth in recent times. There will be a growth from $4.24 billion in 2024 to $4.55 billion in 2025, showcasing a Compound Annual Growth Rate
Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence …
The Pancreatic Cancer Diagnostic Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Pancreatic Cancer Diagnostic Market Size and Projected Growth Rate? There has been a significant expansion in the pancreatic cancer diagnostic market recently. This market is projected to increase from a value
Pancreatic Amylase Reagent Kits: Streamlining Enzyme Analysis for Efficient Panc …
Pancreatic Amylase Reagent Kits Market 2023 Forecast: Unveiling Opportunities and Growth Pancreatic Amylase Reagent Kits Market research report helps to recognize the market challenges and opportunities. Global Pancreatic Amylase Reagent Kits Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of
Pancreatic Cancer Therapy Market: Rise in Number of Patients Suffering with Panc …
Pancreatic cancer is one of the aggressive cancers that originate in the tissues of the pancreas and rapidly spreads to the nearby organs. Pancreatic cancer is the 12th most commonly occurring cancer in the world. According to the American Cancer Society, ~55,440 patients in the US are expected to be diagnosed with pancreatic cancer in 2018. Moreover, the ACS also reports that pancreatic cancer is the third leading cause of